Medication Use Evaluation of Tirzepatide FDA Approved for Type 2 Diabetes in the Outpatient Setting

Authors

Carina Diaz, Baptist Health South FloridaFollow
Sheerida Hosein Mohammed, Baptist Health South FloridaFollow
Emilie Collongette, Baptist Health South FloridaFollow

Files

Publication Date

4-23-2025

Content Type

Poster

Recommended Citation

Diaz, Carina; Hosein Mohammed, Sheerida; and Collongette, Emilie, "Medication Use Evaluation of Tirzepatide FDA Approved for Type 2 Diabetes in the Outpatient Setting" (2025). 2025 Baptist Health Academic Conference: Leading Tomorrow's Healthcare Through Innovation. 212.
https://scholarlycommons.baptisthealth.net/bhsf-academic-week-2025/212